CIBC Private Wealth Group
ONC

CIBC Private Wealth Group’s BeOne Medicines Ltd ONC Stock Holding History

CIBC Private Wealth Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.38K Sell
21
-8
-28% -$2.62K ﹤0.01% 2568
2025
Q3 		$10K Buy
29
+8
+38% +$2.43K ﹤0.01% 2385
2025
Q2 		$5.08K Buy
+21
New +$5.15K ﹤0.01% 2448
2025
Q1 		– Sell
-6
Closed -$1.07K – 3292
2024
Q4 		$1.07K Buy
6
+2
+50% +$409 ﹤0.01% 2792
2024
Q3 		$898 Hold
4
– – ﹤0.01% 2919
2024
Q2 		$577 Hold
4
– – ﹤0.01% 2959
2024
Q1 		$637 Buy
+4
New +$644 ﹤0.01% 2910

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

CIBC Private Wealth Group's ONC Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its BeOne Medicines Ltd (ONC) stake by 28% in Q4 2025, selling an estimated $2.62K and leaving 21 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

CIBC Private Wealth Group first reported a position in ONC in Q1 2024 and has held it in 7 quarters since. The position peaked at $10K in Q3 2025. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • CIBC Private Wealth Group held 21 shares of BeOne Medicines Ltd worth $6.38K as of Q4 2025.
  • CIBC Private Wealth Group sold 8 BeOne Medicines Ltd shares in Q4 2025, an estimated $2.62K.
  • BeOne Medicines Ltd made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2568 holding.
  • CIBC Private Wealth Group first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's BeOne Medicines Ltd position peaked at $10K in Q3 2025.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.